Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2023 | 2023-12-31 | CHF 379 | reported | |
| FY 2022 | 2022-12-31 | CHF 305,616 | reported | |
| FY 2021 | 2021-12-31 | CHF 63,882 | reported |
Altamira Therapeutics Ltd. · CIK 1601936 · Engraved from SEC EDGAR
Altamira Therapeutics Ltd. is the 525th largest of the 565 covered companies the SEC files under this code, by market cap. SIC 2834
Latest filing Feb 27, 2026
The ifrs-full concepts with the most facts on file for this company.
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
No reported open-market purchases or sales in the last 12 months.